News
Sleep apnea cardiovascular endpoints study (SAVE)
AISH is a key member of he SAVE Project; an international multi-centre, randomised controlled trial to determine the effects of nasal continuous positive airway pressure (CPAP) in preventing cardiovascular (CV) disease in high risk patients with obstructive sleep apnea (OSA).
SAVE represents a pivotal research programme involving sleep and CV medicine experts aimed at producing high level evidence to inform clinical decision making and future health policy in a large and increasing area of global disease burden.
SAVE is one of the first projects to commence supported by the Australasian Sleep Trials Network (ASTN).
For more information visit www.savetrial.org today.
<< Back